Bio-Pharm
Handok "Rezolute’s Hyperinsulinism Treatment Receives FDA Breakthrough Therapy Status"
Handok's affiliate, Rezolute, announced on the 7th (local time) that the U.S. Food and Drug Administration (FDA) has…